Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1169 of 5804
-
CBD lotion tested for scleroderma itch in new study
Symptom relief Recruiting nowItching is one of the common symptoms found in patients with scleroderma, with a prevalence of about 42-62%, and it often occurs in the early stages of the disease. The mechanisms of itching are still unclear, and current treatments have not yet shown any clear efficacy in allevi…
Phase: PHASE3 • Sponsor: Khon Kaen University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New hope for HS sufferers: LAD191 enters Mid-Stage trial
Disease control Recruiting nowThe main purpose of this study is to assess the efficacy of multiple dosing regimens of LAD191 compared to placebo in participants with moderate-to-severe Hidradenitis Suppurativa (HS) and to access the safety, tolerability, pharmacokinetic and immunogenicity in participants with…
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New digital tool could empower women traumatized by violence
Symptom relief Recruiting nowThe purpose of the study is to evaluate a trauma informed digital multicomponent intervention design to improve health and safety outcomes for women with lifetime exposures to violence and co-occurring PTSD and/or depression symptoms
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer in kids
Diagnosis Recruiting nowThis is a non-randomized, open label phase Ib/II dose-escalation and expansion study designed to define the recommended dose of anti-GD2-800CW in pediatric neuroblastoma patients. The aim of this imaging study is to determine a safe and effective dose of anti-GD2-800CW for intra-…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Can High-Intensity workouts boost stroke recovery?
Symptom relief Recruiting nowThe aim of this study is to determine comparative effects of High intensity interval training versus Intermittent functional training on cardiovascular fitness, physical function and cognition in stroke.
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Thyroid pill plus diet may boost weight loss in obesity, new trial suggests
Disease control Recruiting nowObesity is a chronic disease with high relapse rates after initial weight loss. Thyroid hormones modulate energy expenditure, body composition, and thermogenesis; higher TSH within the reference range and subclinical hypothyroidism have been associated with adverse metabolic prof…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could an HIV drug help treat rett syndrome?
Disease control ENROLLING_BY_INVITATIONRett syndrome (RTT) is a rare genetic neurodevelopmental disorder caused primarily by mutations in the MECP2 gene, leading to progressive impairments in motor function, communication, and behavior following an initial period of apparently typical development. Currently, there are…
Phase: PHASE2 • Sponsor: Maria Denise Fernandes Carvalho de Andrade • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New CAR T-Cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis is a phase 1 study of FT836 administered in participants with advanced solid tumors. The primary objectives of the study are to evaluate the safety and tolerability of FT836 with or without paclitaxel and/or trastuzumab or cetuximab, and to determine the recommended phase 2 …
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to help vulnerable canadians quit smoking with nicotine spray and cytisine
Disease control ENROLLING_BY_INVITATIONTobacco is the most preventable cause of disease and death in Canada. Although the tobacco use rate has substantially gone down in the general population, significant differences exist between sub-populations in Canada, for example Ottawa's highly vulnerable homeless or at-risk f…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for rare gut cancer: targeted drug enters trial for patients out of options
Disease control Recruiting nowSmall bowel adenocarcinoma is a rare cancer with a poor prognosis. For patients with locally advanced or metastatic disease, the usual first treatment is chemotherapy with platinum-based combinations such as FOLFOX or CapeOX. However, once the cancer grows after this treatment or…
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug SV001 aims to slow lung scarring in IPF patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, PK and immunogenicity of SV001 in patients with idiopathic pulmonary fibrosis.
Phase: PHASE2 • Sponsor: Shanghai Synvida Biotechnology Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Dissolvable heart stent could replace permanent implants
Disease control Recruiting nowImplantation of a metallic drug-eluting stent (DES) is currently the gold standard in percutaneous coronary intervention (PCI). However, a DES has several limitations on the long-term, such as chronic local inflammation which may lead to in-stent restenosis, absence of physiologi…
Sponsor: Albert Schweitzer Ziekenhuis, Netherlands • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a common drug help stroke patients heal faster?
Disease control Recruiting nowThe primary objective of this study is to further define the mechanisms of action of Mexidol® (solution for intravenous and intramuscular injection, 50 mg/ml) and Mexidol® FORTE 250 (film-coated tablets, 250 mg) in the hyperacute and acute periods of ischemic stroke, and to evalu…
Phase: PHASE4 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental combo targets Hard-to-Treat brain cancers
Disease control Recruiting nowThis clinical trial is a 2-phase trial designed to evaluate the safety of tarlatamab in combination with a fixed dose of metronomic temozolomide in adolescents and adults with CNS tumors (stratified into two age-based cohorts), and to assess the clinical activity of this therapeu…
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Colonoscopy may detect Parkinson's before symptoms worsen
Diagnosis Recruiting nowThe goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is: Can doctors find a protein called alpha-s…
Sponsor: CND Life Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New scan could spot hidden prostate cancers, slash unneeded biopsies
Diagnosis Recruiting nowThe goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results. These uncertain results include MRI results that showed a PIRADS 2 or PIRADS 3 area on the prostate. T…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Can your own fat help heal severe burns? new trial aims to find out
Disease control Recruiting nowThe goal of this study is to explore if an adipose-based therapeutic strategy can treat full-thickness soft-tissue trauma wounds in injured individuals, especially those with severe burns or soft-tissue loss. The main question it aims to answer are: \- Can immediate autologous a…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can your own fat heal burn scars better?
Disease control Recruiting nowThe goal of this study is to explore if an adipose-based therapeutic strategy can treat contracted scars secondary to soft-tissue burn wounds in injured individuals, especially those with severe burns or soft-tissue loss. The main question it aims to answer are: \- Can autologou…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New ultrasound technique aims to spot cancer more clearly
Diagnosis Recruiting nowThis is a 4-arm, single-center study involving 40 participants. Ten healthy volunteers will be enrolled for system imaging optimization, and thirty (30) patients with previously identified lesions in the breast, liver, or kidney-based on prior ultrasound or cross-sectional imagin…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Could one hour replace two days? new trial aims to speed up cancer care
Symptom relief Recruiting nowThe goal of this clinical trial is to understand whether the Magnetic Resonance Linear Accelerator (MRL) could expedite Radiotherapy treatment for Metastatic Cord Compression (MSCC) by removing the need for a planning CT (pCT) scan prior to treatment. Radiotherapy will be deliver…
Phase: NA • Sponsor: The Christie NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC